Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-dependent RNA helicase DDX3Y is an enzyme encoded by the DDX3Y gene on the Y chromosome, classified as a member of the DEAD-box RNA helicase family characterized by a conserved Asp-Glu-Ala-Asp (DEAD) motif essential for ATP binding, hydrolysis, and RNA binding activity[2][3][4]. DDX3Y alters RNA secondary structure, participating in various aspects of RNA metabolism such as translation initiation, mRNA splicing, and ribosome and spliceosome assembly[2][3]. It is highly expressed in male germ cells, is crucial for spermatogenesis, and mutations or deletions lead to male infertility including Sertoli cell-only syndrome and severe hypospermatogenesis[2][3]. The protein shares high sequence similarity to its X chromosome paralog DDX3X, but its spermatogenic function is not complemented by DDX3X[3]. DDX3Y is also implicated in immune response, with a potential role in enhancing interferon beta (IFNB1) expression during immune activation[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-dependent RNA helicase DDX3Y (DDX3Y).